Balance Sheet

Cash Flow Statement

Amortization Amortization Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Change in Working Capital Change in Working Capital Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Legend Biotech (LEGN) Net Income (2019 - 2025)

Legend Biotech filings provide 7 years of Net Income readings, the most recent being -$8.5 million for Q4 2025.

On a quarterly basis, Net Income fell 115.54% to -$8.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$70.3 million, a 49.56% increase, with the full-year FY2025 number at -$268.4 million, down 92.82% from a year prior.
Net Income hit -$8.5 million in Q4 2025 for Legend Biotech, up from -$38.5 million in the prior quarter.
In the past five years, Net Income ranged from a high of $112.1 million in Q1 2023 to a low of -$198.5 million in Q2 2023.
Median Net Income over the past 5 years was -$61.3 million (2023), compared with a mean of -$55.3 million.
Biggest five-year swings in Net Income: crashed 32288.91% in 2022 and later soared 36859.27% in 2024.
Legend Biotech's Net Income stood at -$84.7 million in 2021, then tumbled by 60.02% to -$135.6 million in 2022, then surged by 99.89% to -$148806.0 in 2023, then soared by 36859.27% to $54.7 million in 2024, then plummeted by 115.54% to -$8.5 million in 2025.
The last three reported values for Net Income were -$8.5 million (Q4 2025), -$38.5 million (Q3 2025), and -$124.2 million (Q2 2025) per Business Quant data.